Pulses of light may offer ward against mosquitos
June 19, 2017Research and Development, Sales and Marketing malaria, mosquito
Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …
First-of-its-kind blood test unlocks precision treatment options for prostate cancer
June 19, 2017Research and Development, Sales and Marketing
AstraZeneca’s Lynparza (olparib) is making yet another impact following its impressive showing this month in the ovarian cancer space, with …
Novartis receives European biosimilar approval for Roche blockbuster
June 19, 2017Sales and Marketing Novartis, Rituxan, Rixathon, Roche
Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …
Top Ten most popular articles on Pharmafile.com this week
June 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …
Shooting for the moon: The National Cancer Institute’s Formulary
June 16, 2017Medical Communications, Research and Development NCI
Pharmafile spoke to National Cancer Institute’s (NCI) Jason Christofaro and Sherry Ansher regarding the development of an agent formulary and its role …
Drug that induces tanning could protect against melanoma
June 16, 2017Medical Communications, Research and Development melanoma, skin cancer, sun
People will often go to extraordinary lengths to achieve tanned skin but researchers have found a potential method that does …
Cambridge start-up secures £40 million to trial innovative cancer drugs
June 16, 2017Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer
Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …
New rival to EpiPen receives FDA approval to shake up market
June 16, 2017Medical Communications, Sales and Marketing Adamis, Mylan, Symjepi, epipen
Adamis Pharmaceuticals has revealed that it received FDA approval for its EpiPen rival to enter the market. Its product, to …
From pipeline to patients: Navigating treatments through the UK system
June 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline
Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …
Weakness discovered in malaria parasite could lead to new treatment
June 15, 2017Protein, anti-malarial drug resistance, malaria, mosquito
A protein has been newly discovered that could lead to an alternative form of vaccination against the spread of malaria …
FDA fast-tracks Pfizer and Lilly’s chronic pain drug
June 15, 2017Research and Development, Sales and Marketing Eli Lilly, FDA, Pfizer
Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the …
EMA lags behind FDA on continuous manufacturing regulation
June 15, 2017Manufacturing and Production EMA, FDA, continuous manufacturing
Continuous manufacturing is increasingly an area of fixation within the pharma industry for the benefits it can bring to the …
Novartis’ Cosentyx shines in ankylosing spondylitis and psoriatic arthritis
June 15, 2017Research and Development Cosentyx, Novartis
Novartis has released new data on the efficacy of its drug Cosentyx (secukinumab) in the treatment of life-long inflammatory diseases …
LifeArc rebrands and sets up £500m research fund
June 15, 2017Medical Communications, Research and Development, Sales and Marketing LifeArc, MRC Technology, keytruda
The UK medical research charity formerly known as MRC Technology has rebranded to be known as LifeArc. At the same …
Trump appoints new Director of the National Cancer Institute
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing National Cancer Institute, appointment
Dr Norman Sharpless has been named as Director of the National Cancer Institute (NCI), part of the National Institutes of …
PrimeVigilance is committed to minimising the impact of UK’s Withdrawal from the EU
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, primevigilance
Guildford, UK 14th June, 2017
Alexion secures ex-Biogen Chief Financial Officer
June 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, Biogen, appointment
Alexion Pharmaceuticals has announced that it has snatched up Biogen’s long-serving Chief Financial Officer Paul Clancy and will instate him …
Bhutan and Maldives successfully eliminate measles
June 14, 2017Medical Communications, Research and Development WHO, immunisation, measles, rubella
The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …
Celltrion biosimilar proves effectiveness in lymphoma and rheumatoid arthritis
June 14, 2017Research and Development Cellltrion, Truxima, biosimilar, lymphoma, rheumatoid arthritis, rutiximab
Celltrion Healthcare has revealed new data which validates its biosimilar Truxima (CT-P10) as non-inferior to its reference product rituximab in …
Reversal of type 1 diabetes possible through century-old vaccine
June 14, 2017Research and Development BCG, Type 1 diabetes, Vaccine, diabetes
The American Diabetes Association 77th Scientific Sessions closed yesterday and one of the most interesting pieces of research to emerge …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
